key: cord-1021742-b7zw63u0
authors: Zhang, Bin; Zhang, Shuixing
title: Corticosteroids‐induced osteonecrosis in COVID‐19: a call for caution
date: 2020-07-22
journal: J Bone Miner Res
DOI: 10.1002/jbmr.4136
sha: e58f781f1795dad398b3234f7fdb19b447f3a672
doc_id: 1021742
cord_uid: b7zw63u0

nan

This article is protected by copyright. All rights reserved.

were treated with steroid, the incidence of steroid-induced ONFH was 24.1% (5) . This study suggested that the male, younger age, total dose of steroids and the use of more than one type of steroid were associated with an increased incidence of ONFH (5) . During long-term follow-up of SARS patients 7 years after steroid administration, Zhao et al. found that larger lesions and less viable lateral column were the crucial risk factors for progression of ONFH and small ONFH lesions seldom collapsed (6) .

Corticosteroids should be administered with caution, including minimizing dose and duration, avoiding the use of multiple types. New drugs such as tocilizumab, may be an alternative to control the cytokine storm instead of corticosteroids (7) . We should develop a risk stratification system of ONFH for COVID-19 patients (8) could also be alternatives (9) . Physical therapy and combined pharmacotherapy can be used to delay or prevent collapse of steroid-induced ONFH in early stage (10) .

The authors declare no competing interests.

Osteoporosis Management in the Era of COVID-19

High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19

Guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection (trial version 7) (in Chinese). National Health Commission of the People's Republic of China

Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis

The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study

Osteonecrosis of the femoral head in SARS patients: seven years later

Corticosteroids in diabetes patients infected with COVID-19

Expert consensus on prevention and treatment of osteonecrosis of the femoral head (ONFH) after COVID-19 with Traditional Chinese medicine

Caution against corticosteroid-based COVID-19 treatment

Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up